Editas Medicine, Inc. (EDIT)
NASDAQ·Healthcare·Biotechnology
$3.07
+6.06%
Mkt Cap $282.85M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 9, 2026 | $8.35M | $24.74M | +196.33% | -$0.27 | -$0.06 | +77.78% | — | — |
| Q4 2025 Nov 10, 2025 | $8.45M | $7.54M | -10.77% | -$0.38 | -$0.28 | +26.32% | — | — |
| Q3 2025 Aug 12, 2025 | $1.82M | $3.58M | +97.05% | -$0.41 | -$0.63 | -53.66% | — | — |
| Q2 2025 May 12, 2025 | $706.10K | $4.66M | +559.68% | -$0.51 | -$0.43 | +15.69% | — | — |
| Q1 2025 Mar 5, 2025 | $640.25K | $30.60M | +4680.01% | -$0.39 | -$0.55 | -41.03% | — | — |
| Q4 2024 Nov 4, 2024 | $28.90M | $61.00K | -99.79% | -$0.76 | -$0.75 | +1.32% | — | — |
| Q3 2024 Aug 7, 2024 | $5.08M | $513.00K | -89.90% | -$0.69 | -$0.82 | -18.84% | — | — |
| Q2 2024 May 8, 2024 | $7.90M | $1.14M | -85.63% | -$0.63 | -$0.76 | -20.63% | — | — |
| Q1 2024 Feb 28, 2024 | $7.94M | $60.05M | +656.28% | -$0.52 | -$0.23 | +55.77% | — | — |
| Q4 2023 Nov 3, 2023 | $3.42M | $5.34M | +56.02% | -$0.64 | -$0.55 | +14.06% | — | — |
| Q3 2023 Aug 2, 2023 | $4.17M | $2.89M | -30.77% | -$0.76 | -$0.56 | +26.32% | — | — |
| Q2 2023 May 5, 2023 | $3.01M | $9.85M | +227.28% | -$0.79 | -$0.71 | +10.13% | — | — |
| Q1 2023 Feb 22, 2023 | $3.66M | $6.54M | +78.68% | -$0.84 | -$0.88 | -4.76% | — | — |
| Q4 2022 Nov 2, 2022 | $4.39M | $42.00K | -99.04% | -$0.87 | -$0.81 | +6.90% | — | — |
| Q3 2022 Aug 3, 2022 | $4.29M | $6.36M | +48.28% | -$0.84 | -$0.78 | +7.14% | — | — |
| Q2 2022 May 4, 2022 | $3.85M | $6.77M | +75.76% | -$0.81 | -$0.74 | +8.64% | — | — |
| Q1 2022 Feb 24, 2022 | $4.64M | $12.47M | +168.51% | -$0.78 | -$0.61 | +21.79% | — | — |
| Q4 2021 Nov 8, 2021 | $5.67M | $6.20M | +9.29% | -$0.86 | -$0.57 | +33.72% | — | — |
| Q3 2021 Aug 4, 2021 | $379.00K | $379.00K | +0.00% | -$0.85 | -$0.81 | +4.71% | — | — |
| Q2 2021 May 5, 2021 | $6.37M | $6.50M | +2.03% | -$0.76 | -$0.86 | -13.16% | — | — |